 | Up a level |
Rovó, Alicia; Gras, Luuk; Piepenbroek, Brian; Kröger, Nicolaus; Reinhardt, Christian H.; Radujkovic, Aleksandar; Blaise, Didier; Kobbe, Guido; Niityvuopio, Riitta; Platzbecker, Uwe; Sockel, Katja; Hunault-Berger, Mathilde; Cornelissen, J J; Forcade, Edouard; Bourhis, Jean Henri; Chalandon, Yves; Kinsella, Francesca; Nguyen-Quoc, Stéphanie; Maertens, Johan; Elmaagacli, Ahmet; ... (2024). Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT. American journal of hematology, 99(2), pp. 203-215. Wiley-Liss 10.1002/ajh.27150
Versluis, J; In 't Hout, F E M; Devillier, R; van Putten, W L J; Manz, M G; Vekemans, M-C; Legdeur, M-C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J M; van der Reijden, B A; Meloni, G; Schouten, H C; Vellenga, E; Pabst, Thomas; Willemze, R; Löwenberg, B; Ossenkoppele, G; ... (2017). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1), pp. 26-33. Nature Publishing Group 10.1038/leu.2016.183
Cornelissen, J J; Versluis, J; Passweg, Jakob; van Putten, W L J; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J M; van Marwijk Kooy, M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M-C; Breems, D A; Verdonck, L F; Fey, Martin; Jongen-Lavrencic, M; Janssen, J J W M; Huls, G; Kuball, J; ... (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5), pp. 1041-1050. Nature Publishing Group 10.1038/leu.2014.332
